Early intervention in rare disease can save lives, Centre's policy an encouraging step - Moneycontrol

Retrieved on: 2022-09-29 09:50:49

Tags for this article:

Neurological disorders

Neurodegenerative disorders

Pharmaceutical industry

Health

RTT

Spinal muscular atrophy

Medication

Rare disease

Specialty drugs in the United States

Tuberculosis management

India

Roche

Click the tags to see associated articles and topics

Early intervention in rare disease can save lives, Centre's policy an encouraging step - Moneycontrol. View article details on HISWAI: https://www.moneycontrol.com/news/trends/early-intervention-in-rare-disease-can-save-lives-centres-policy-an-encouraging-step-bruno-jolain-roche-india-9249941.html

Excerpt

Pharma major Roche's Evrysdi is the first and only approved treatment available in India for patients suffering from spinal muscular atrophy (SMA) ...

Article found on: www.moneycontrol.com

View Original Article